JP2023500707A5 - - Google Patents
Info
- Publication number
- JP2023500707A5 JP2023500707A5 JP2022526059A JP2022526059A JP2023500707A5 JP 2023500707 A5 JP2023500707 A5 JP 2023500707A5 JP 2022526059 A JP2022526059 A JP 2022526059A JP 2022526059 A JP2022526059 A JP 2022526059A JP 2023500707 A5 JP2023500707 A5 JP 2023500707A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962931132P | 2019-11-05 | 2019-11-05 | |
| US62/931,132 | 2019-11-05 | ||
| US202063046143P | 2020-06-30 | 2020-06-30 | |
| US63/046,143 | 2020-06-30 | ||
| PCT/US2020/059200 WO2021092239A1 (en) | 2019-11-05 | 2020-11-05 | Topical compositions comprising irak4 inhibitors for use in treating dermatological conditions characterised by inflammation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500707A JP2023500707A (ja) | 2023-01-10 |
| JPWO2021092239A5 JPWO2021092239A5 (https=) | 2023-12-15 |
| JP2023500707A5 true JP2023500707A5 (https=) | 2023-12-15 |
Family
ID=73654894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526059A Ceased JP2023500707A (ja) | 2019-11-05 | 2020-11-05 | 炎症を特徴とする皮膚科状態の治療に使用するためのｉｒａｋ４阻害剤を含む局所用組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230125380A1 (https=) |
| EP (1) | EP4054573A1 (https=) |
| JP (1) | JP2023500707A (https=) |
| CN (2) | CN118806758A (https=) |
| AU (1) | AU2020380921A1 (https=) |
| BR (1) | BR112022008610A2 (https=) |
| CA (1) | CA3159624A1 (https=) |
| IL (1) | IL292689A (https=) |
| WO (1) | WO2021092239A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3186630A1 (en) * | 2020-06-30 | 2022-01-06 | Dermira, Inc. | Irak4 inhibitors and topical uses thereof |
| CN118530374B (zh) * | 2023-06-02 | 2025-11-04 | 东北农业大学 | 犬成纤维细胞生长因子21融合蛋白制备及其在治疗特应性皮炎中的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105899505B (zh) | 2013-11-08 | 2018-08-28 | 武田药品工业株式会社 | 用于治疗自身免疫病症的吡唑 |
| BR112018000624A2 (pt) * | 2015-07-15 | 2018-09-18 | Aurigene Discovery Technologies Limited | compostos de indazol e azaindazol como inibidores de irak-4 |
| WO2017205762A1 (en) * | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
| EP3727428A1 (en) * | 2017-12-20 | 2020-10-28 | Translate Bio, Inc. | Improved composition and methods for treatment of ornithine transcarbamylase deficiency |
| IL315310A (en) * | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| CA3186630A1 (en) * | 2020-06-30 | 2022-01-06 | Dermira, Inc. | Irak4 inhibitors and topical uses thereof |
-
2020
- 2020-11-05 US US17/771,777 patent/US20230125380A1/en not_active Abandoned
- 2020-11-05 CN CN202410650258.XA patent/CN118806758A/zh active Pending
- 2020-11-05 BR BR112022008610A patent/BR112022008610A2/pt unknown
- 2020-11-05 CN CN202080087596.7A patent/CN114929223A/zh active Pending
- 2020-11-05 AU AU2020380921A patent/AU2020380921A1/en active Pending
- 2020-11-05 CA CA3159624A patent/CA3159624A1/en active Pending
- 2020-11-05 WO PCT/US2020/059200 patent/WO2021092239A1/en not_active Ceased
- 2020-11-05 EP EP20817122.3A patent/EP4054573A1/en not_active Withdrawn
- 2020-11-05 JP JP2022526059A patent/JP2023500707A/ja not_active Ceased
-
2022
- 2022-05-02 IL IL292689A patent/IL292689A/en unknown